www.alk.net
  • Your allergy
    • What is allergy
      • House dust mite allergy
      • Pollen allergy
      • Living with allergy
      • Socio-economic impact
    • What is allergic asthma
    • How is allergy diagnosed
    • Treating allergy
  • Our solutions
    • Consumer healthcare
    • Diagnostics
    • Allergy vaccines
      • Production
    • Emergency medicine
  • Our science
    • Allergy immunotherapy
    • Healthcare professionals
      • Reweal
      • Webinars
    • Pipeline
    • Clinical trials
    • Clinical data sharing
  • Our company
    • Newsroom
      • Stories
    • Privacy
    • Global presence
    • Organisation
    • History
    • Owners
  • Sustainability
  • Investors
    • Overview
    • Financial reporting
      • Risk management
      • Reporting standards
      • Auditors
    • Governance
      • Board of Management
      • Board of Directors
      • Annual general meeting
      • Annual general meeting (DK)
    • News & Events
      • Company Releases
      • Company releases (DK)
      • Webcasts & presentations
      • Investor calendar
    • The Share
      • Dividend history
      • Analyst coverage
      • Analyst estimates
      • Shareholder information
      • Authorizations
      • ADR Programme
    • Contact IR
  • Careers
    • Working at ALK
    • Vacant positions
    • Cultural Beliefs
  • Select country
Search

Shareholder information

Links: 
Dividend history
Analyst coverage
Analyst estimates
Shareholder information
Authorizations
ADR Programme

Ownership

On 31 December 2022, ALK had 27,960 registered shareholders versus 20,434 at the end of 2021. The registered shareholders owned 97.2% of the share capital (98%).

To support the liquidity of the share, in 2022 ALK completed a share split at a ratio of 1:20, whereby each share, with a nominal value of DKK 10, was split into 20 new shares with a nominal value of DKK 0.50.

Following the share split, the share capital of DKK 111,411,960 was divided into 18,415,200 A shares, 1,841,520 AA shares and 202,567,200 B shares. All B shares are listed on Nasdaq Copenhagen and freely negotiable. The A and AA shares are not listed and are predominantly held by the Lundbeck Foundation, an enterprise foundation whose purpose is to strengthen brain health and develop the Danish business sector.

Two shareholders have reported to ALK that they held 5% or more of the shares on 31 December 2022:

  • The Lundbeck Foundation (Copenhagen, Denmark): 40.3% incl. A and AA shares
  • ATP (Hillerød, Denmark): 5.1%

Of the largest registered shareholders, the vast majority were institutional investors, and largely from Europe and North America. The international registered ownership was estimated at approximately 33% (31%), representing 55% of the free float of the B shares, excluding the Lundbeck Foundation’s holding and treasury shares.

To meet obligations to deliver shares under management incentive programmes, ALK held 1,824,975 of its own shares, or 0.8% of the share capital, versus 1.3% at the end of 2021. The holding was reduced following the settlement of share option and performance share programmes.

The Board of Directors and Board of Management held a total of 275,312 shares at year-end, corresponding to 0.1% of the share capital (0.1%).

 

Shareholders and treasury shares as at 31 December 2022
 

The Lundbeck Foundation

Registered office: Copenhagen, Denmark

A shares, number: 920,720

AA shares, number: 92,072

B shares number: 3,474,827

Interest: 40.3%

Votes: 67.2%
 

ATP*

Registered office: Hillerød, Denmark

B shares, number: 11,461,329

Interest: 5.1%

Votes: 2.8%
 

ALK – treasury shares

Registered office: Hørsholm, Denmark

B shares, number: 1,824,975 B shares

Interest: 0.8%
 

Other

A shares, number: 800

AA shares, number: 80

B shares number: 119,784,356

Interest: 53.8%

Votes: 29.5%

 

* The Danish Labour Market Supplementary Pension

 
  • Email Alerts

    Email Alerts

  • Downloads

    Downloads

  • RSS

    RSS

  • Print

    Print

  • Share

    Share

  • English

    English

  • Search

    Search




Select Country Menu

  • Change Country

Quick Links

  • Contact us
  • News
  • Media
  • Vacant jobs
  • Products

ALK Footer Copyright Text

ALK-Abelló A/S ∙ Bøge Allé 6 ∙ DK-2970 Hørsholm ∙ Denmark ∙ CVR no. 63717916 ∙ T +45 45 74 75 76 Legal disclaimer © ALK ∙ All rights reserved